The characteristics of an ideal inhaler are based around the design and formulation of the device, patient use and the clinical effect, together with concordance and patient preference. To ensure ...

In both the Easyhaler DPI and Evohaler pMDI cohorts, 98.3% of patients with asthma recovered FEV1 to at least -10% of baseline after their last treatment post MC test. Investigators sought to ...

Propeller Health is partnering up with Orion to bring its digital inhaler platform to the Finnish drugmaker’s Easyhaler line of products. The 2015 Fierce 15 company will help develop a small, custom ...

A new inhaler has been shown to increase overall asthma control with no associated cost increase, according to a recent UK study. The study featured 1958 patients with asthma – both children and ...

Reducing the use of metered-dose inhalers for asthma could shrink the carbon footprint while achieving cost savings if less expensive brands of dry powder inhalers are used, according to new research ...

Nycomed, which is in the process of being acquired by Takeda, and Finland's Orion Corp, are looking to co-market generics of two respiratory blockbusters - GlaxoSmithKline's Advair and AstraZeneca's ...

In conclusion, the Easyhaler ® more closely demonstrates the characteristics of an ‘ideal inhaler' than its competitors (consistent fine particle dose, performance regardless of inspiration rate, ...